[1] Okubo, K., Kurono, Y., Ichimura, K., Enomoto, T., et al., Japanese guidelines for allergic rhinitis 2020. Allergol Int 2020.
[2] Bousquet, J., Schünemann, H. J., Togias, A., Bachert, C., et al., Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol 2020, 145, 70-80.e73.
[3] Galli, S. J., Tsai, M., IgE and mast cells in allergic disease. Nat Med 2012, 18, 693- 704.
[4] Harvima, I. T., Levi-Schaffer, F., Draber, P., Friedman, S., et al., Molecular targets on mast cells and basophils for novel therapies. J Allergy Clin Immunol 2014, 134, 530- 544.
[5] Thorburn, A. N., McKenzie, C. I., Shen, S., Stanley, D., et al., Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun 2015, 6, 7320.
[6] Tan, J., McKenzie, C., Vuillermin, P. J., Goverse, G., et al., Dietary Fiber and Bacterial SCFA Enhance Oral Tolerance and Protect against Food Allergy through Diverse Cellular Pathways. Cell Rep 2016, 15, 2809-2824.
[7] Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., et al., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014, 20, 159-166.
[8] Zhang, Y. F., Liu, Q. M., Gao, Y. Y., Liu, B., et al., Attenuation of allergic responses following treatment with resveratrol in anaphylactic models and IgE-mediated mast cells. Food Funct 2019, 10, 2030-2039.
[9] Fujimura, Y., Umeda, D., Yano, S., Maeda-Yamamoto, M., et al., The 67kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG. Biochem Biophys Res Commun 2007, 364, 79-85.
[10] Zárate, R., El Jaber-Vazdekis, N., Tejera, N., Pérez, J. A., Rodríguez, C., Significance of long chain polyunsaturated fatty acids in human health. Clin Transl Med 2017, 6, 25.
[11] Hogenkamp, A., Ehlers, A., Garssen, J., Willemsen, L. E. M., Allergy Modulation by N-3 Long Chain Polyunsaturated Fatty Acids and Fat Soluble Nutrients of the Mediterranean Diet. Front Pharmacol 2020, 11, 1244.
[12] Dyerberg, J., Bang, H. O., Stoffersen, E., Moncada, S., Vane, J. R., Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978, 2, 117-119.
[13] Fussbroich, D., Colas, R. A., Eickmeier, O., Trischler, J., et al., A combination of LCPUFA ameliorates airway inflammation in asthmatic mice by promoting pro- resolving effects and reducing adverse effects of EPA. Mucosal Immunol 2020, 13, 481-492.
[14] van den Elsen, L. W., Bol-Schoenmakers, M., van Esch, B. C., Hofman, G. A., et al., DHA-rich tuna oil effectively suppresses allergic symptoms in mice allergic to whey or peanut. J Nutr 2014, 144, 1970-1976.
[15] Kunisawa, J., Arita, M., Hayasaka, T., Harada, T., et al., Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut. Sci Rep 2015, 5, 9750.
[16] Hirakata, T., Lee, H. C., Ohba, M., Saeki, K., et al., Dietary omega-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T. FASEB J 2018, fj201801805R.
[17] Tsuge, K., Inazumi, T., Shimamoto, A., Sugimoto, Y., Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases. Int Immunol 2019, 31, 597-606.
[18] Serhan, C. N., Levy, B. D., Resolvins in inflammation: emergence of the pro- resolving superfamily of mediators. J Clin Invest 2018, 128, 2657-2669.
[19] Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., Levy, B. D., Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 2008, 9, 873-879.
[20] Sawada, Y., Honda, T., Hanakawa, S., Nakamizo, S., et al., Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses. J Exp Med 2015, 212, 1921-1930.
[21] Nagatake, T., Shiogama, Y., Inoue, A., Kikuta, J., et al., The 17,18- epoxyeicosatetraenoic acid-G protein-coupled receptor 40 axis ameliorates contact hypersensitivity by inhibiting neutrophil mobility in mice and cynomolgus macaques. J Allergy Clin Immunol 2017.
[22] Saika, A., Nagatake, T., Kishino, S., Park, S. B., et al., 17(S),18(R)- epoxyeicosatetraenoic acid generated by cytochrome P450 BM-3 from Bacillus megaterium inhibits the development of contact hypersensitivity via G-protein- coupled receptor 40-mediated neutrophil suppression. FASEB Bioadv 2020, 2, 59-71.
[23] Kim, D. Y., Fukuyama, S., Nagatake, T., Takamura, K., et al., Implications of nasopharynx-associated lymphoid tissue (NALT) in the development of allergic responses in an allergic rhinitis mouse model. Allergy 2012, 67, 502-509.
[24] Takamura, K., Fukuyama, S., Nagatake, T., Kim, D. Y., et al., Regulatory role of lymphoid chemokine CCL19 and CCL21 in the control of allergic rhinitis. J Immunol 2007, 179, 5897-5906.
[25] Nishijima, H., Kondo, K., Toma-Hirano, M., Iwasaki, S., et al., Denervation of nasal mucosa induced by posterior nasal neurectomy suppresses nasal secretion, not hypersensitivity, in an allergic rhinitis rat model. Lab Invest 2016, 96, 981-993.
[26] Eum, S. Y., Maghni, K., Hamid, Q., Eidelman, D. H., et al., Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J Allergy Clin Immunol 2003, 111, 1049-1061.
[27] Nakano, Y., Kidani, Y., Goto, K., Furue, S., et al., Role of Prostaglandin D2 and DP1 Receptor on Japanese Cedar Pollen-Induced Allergic Rhinitis in Mice. J Pharmacol Exp Ther 2016, 357, 258-263.
[28] Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., et al., Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun 2012, 3, 1034.
[29] Tiwari, P., Nagatake, T., Hirata, S. I., Sawane, K., et al., Dietary coconut oil ameliorates skin contact hypersensitivity through mead acid production in mice. Allergy 2019.
[30] Lu, T. X., Rothenberg, M. E., Bone Marrow Derived Eosinophil Cultures. Bio Protoc 2014, 4.
[31] Miyata, J., Fukunaga, K., Iwamoto, R., Isobe, Y., et al., Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J Allergy Clin Immunol 2013, 131, 353-360.e351-352.
[32] Miyata, J., Fukunaga, K., Kawashima, Y., Watanabe, T., et al., Dysregulated fatty acid metabolism in nasal polyp-derived eosinophils from patients with chronic rhinosinusitis. Allergy 2019.
[33] Isobe, Y., Itagaki, M., Ito, Y., Naoe, S., et al., Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid. Sci Rep 2018, 8, 7954.
[34] Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., Aukema, H. M., Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. Adv Nutr 2015, 6, 513- 540.
[35] Varricchi, G., Bagnasco, D., Borriello, F., Heffler, E., Canonica, G. W., Interleukin- 5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs. Curr Opin Allergy Clin Immunol 2016, 16, 186-200.
[36] Kimura, I., Ichimura, A., Ohue-Kitano, R., Igarashi, M., Free Fatty Acid Receptors in Health and Disease. Physiol Rev 2020, 100, 171-210.
[37] Honda, T., Kabashima, K., Prostanoids in allergy. Allergol Int 2015, 64, 11-16.
[38] Marion-Letellier, R., Savoye, G., Ghosh, S., Fatty acids, eicosanoids and PPAR gamma. Eur J Pharmacol 2016, 785, 44-49.
[39] Lee, J. E., Zhang, Y. L., Han, D. H., Kim, D. Y., Rhee, C. S., Antiallergic Function of KR62980, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in a Mouse Allergic Rhinitis Model. Allergy Asthma Immunol Res 2015, 7, 256-264.
[40] Tachibana, M., Wada, K., Katayama, K., Kamisaki, Y., et al., Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases. Allergy 2008, 63, 1136-1147.
[41] Zhang, Y., Li, X., Fang, S., Zhu, Z., et al., Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis. Mol Med Rep 2017, 16, 1793-1800.
[42] Albracht-Schulte, K., Kalupahana, N. S., Ramalingam, L., Wang, S., et al., Omega- 3 fatty acids in obesity and metabolic syndrome: a mechanistic update. J Nutr Biochem 2018, 58, 1-16.
[43] Caligiuri, S. P., Aukema, H. M., Ravandi, A., Guzman, R., et al., Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase. Hypertension 2014, 64, 53-59.
[44] Willemsen, L. E. M., Dietary n-3 long chain polyunsaturated fatty acids in allergy prevention and asthma treatment. Eur J Pharmacol 2016, 785, 174-186.
[45] Fussbroich, D., Zimmermann, K., Göpel, A., Eickmeier, O., et al., A specific combined long-chain polyunsaturated fatty acid supplementation reverses fatty acid profile alterations in a mouse model of chronic asthma. Lipids Health Dis 2019, 18, 16.
[46] Endo, J., Sano, M., Isobe, Y., Fukuda, K., et al., 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med 2014, 211, 1673-1687.
[47] Schwab, J. M., Chiang, N., Arita, M., Serhan, C. N., Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447, 869-874.
[48] Gobbetti, T., Dalli, J., Colas, R. A., Federici Canova, D., et al., Protectin D1n-3DPA and resolvin D5n-3DPA are effectors of intestinal protection. Proc Natl Acad Sci U S A 2017, 114, 3963-3968.
[49] Mochimaru, T., Fukunaga, K., Miyata, J., Matsusaka, M., et al., 12-OH-17,18- Epoxyeicosatetraenoic acid alleviates eosinophilic airway inflammation in murine lungs. Allergy 2018, 73, 369-378.
[50] Weller, P. F., Spencer, L. A., Functions of tissue-resident eosinophils. Nat Rev Immunol 2017, 17, 746-760.
[51] Elishmereni, M., Bachelet, I., Nissim Ben-Efraim, A. H., Mankuta, D., Levi-Schaffer, F., Interacting mast cells and eosinophils acquire an enhanced activation state in vitro. Allergy 2013, 68, 171-179.
[52] Arnold, I. C., Artola-Borán, M., Tallón de Lara, P., Kyburz, A., et al., Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med 2018, 215, 2055-2072.
[53] Mesnil, C., Raulier, S., Paulissen, G., Xiao, X., et al., Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest 2016, 126, 3279-3295.
[54] Yamada, T., Tani, Y., Nakanishi, H., Taguchi, R., et al., Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J 2011, 25, 561-568.
[55] Isobe, Y., Arita, M., Matsueda, S., Iwamoto, R., et al., Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18- dihydroxyeicosapentaenoic acid. J Biol Chem 2012, 287, 10525-10534.
[56] Arita, M., Eosinophil polyunsaturated fatty acid metabolism and its potential control of inflammation and allergy. Allergol Int 2016, 65 Suppl, S2-5.
[57] Ninomiya, T., Nagata, M., Hata, J., Hirakawa, Y., et al., Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study. Atherosclerosis 2013, 231, 261-267.
[58] Wang, X., Ma, D. W., Kang, J. X., Kulka, M., n-3 Polyunsaturated fatty acids inhibit Fc ε receptor I-mediated mast cell activation. J Nutr Biochem 2015, 26, 1580-1588.
[59] Arita, M., Bianchini, F., Aliberti, J., Sher, A., et al., Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005, 201, 713-722.
[60] Arita, M., Ohira, T., Sun, Y. P., Elangovan, S., et al., Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007, 178, 3912-3917.
[61] Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., et al., Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 2010, 107, 1660-1665.
[62] Xia, J., Abdu, S., Maguire, T. J. A., Hopkins, C., et al., Prostaglandin D2 receptors in human mast cells. Allergy 2020, 75, 1477-1480.
[63] Maślanka, T., Otrocka-Domagała, I., Zuśka-Prot, M., Gesek, M., Beneficial effects of rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, in a mouse allergic asthma model is not associated with the recruitment or generation of Foxp3- expressing CD4. Eur J Pharmacol 2019, 848, 30-38.
[64] Belvisi, M. G., Hele, D. J., Birrell, M. A., Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. Eur J Pharmacol 2006, 533, 101-109.
[65] Yamada, H., Oshiro, E., Kikuchi, S., Hakozaki, M., et al., Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs. J Lipid Res 2014, 55, 895-904.
[66] Sawane, K., Nagatake, T., Hosomi, K., Hirata, S. I., et al., Dietary Omega-3 Fatty Acid Dampens Allergic Rhinitis via Eosinophilic Production of the Anti-Allergic Lipid Mediator 15-Hydroxyeicosapentaenoic Acid in Mice. Nutrients 2019, 11.
論文の公開元へ
